Apothekcon, Inc. an independent medical writing service provider specializing in the pharmaceutical, medical device and allied industries. We have a proven track record with over 100 peer reviewed publications.
Dedicated
- Proven medical and scientific writing skills
Collaborative
- Ability to work collaboratively across disciplines to achieve common goals
Experienced
- Medical communications experience with both professional and public audiences
Proven
- Current clients in the pharmaceutical, biotechnology, medical device and related industries
- Dermatology
- Endocrinology
- Gastroenterology
- Infectious Disease
- Neurology
- Oncology
- Ophthalmology
- Sleep Disorders
- Toxicology
- Endocrinology
- Gastroenterology
- Metabolic Disease
- Oncology
- Cardiology
- Dermatology
- Gynecology
- Infectious Disease
- Oncology
- Organ Transplantation
Let us use our years of experience to help you and your organization.
- Investigator Brochures
- Manuscript Editing & Formatting
- Newsletters
- Patient Education Materials
- Poster Presentations
- Abstracts
- Book Chapters
- Case Reports
- Clinical Narratives
- Clinical Trial Manuscripts
- Clinical Study Reports
- Product Monographs
- Research Manuscripts
- Review Articles
- Standard Response Letters
- White Papers
BioMarin Pharmaceutical – Phenylketonuria
Relative bioavailability of sapropterin from intact and dissolved sapropterin dihydrochloride tablets and the effects of food: a randomized, open-label, crossover study in healthy adults.
BioMarin Pharmaceutical – Mucopolysaccharidosis
Pharmacodynamics, pharmacokinetics and biodistribution of recombinant human N-acetylgalactosamine 4-sulfatase after 6 months of therapy in cats using different IV infusion durations.
Merz
Combined use of microfocused ultrasound and a calcium hydroxylapatite dermal filler for treating atrophic acne scars: a pilot study.
Calcium hydroxylapatite combined with microneedling and ascorbic acid is effective for treating stretch marks.
Ulthera
Combining microfocused ultrasound with botulinum toxin and temporary and semi-permanent dermal fillers: safety and current use.
Multicenter pivotal study of vacuum-assisted precise tissue release for the treatment of cellulite.
Erchonia Corporation
Low-level laser therapy for reducing the hip, waist, and upper abdomen circumference of individuals with obesity.
A six-week low-level laser therapy protocol is effective for reducing waist, hip, thigh, and upper abdomen circumference.
Medicis Pharmaceutical Corporation
Persistence of nasolabial fold correction with a hyaluronic acid dermal filler with retreatment: results of an 18-month extension study.
Efficacy and safety of clindamycin phosphate 1.2% and tretinoin 0.025% gel for the treatment of acne and acne-induced post-inflammatory hyperpigmentation in patients with skin of color.
Revance Therapeutics
Safety and efficacy of RT002, an injectable botulinum toxin Type A, for treating glabellar lines: results of a phase 1/2, open-label, sequential dose-escalation study.
Nonsurgical periorbital and brow rejuvenation.
Ferndale Pharma Group, Inc.
Safety and efficacy of oral Polypodium leucotomos extract in healthy adult subjects.
Polypodium leucotomos extract: a status report on clinical efficacy and safety.
Suneva Medical, Inc.
The psychosocial impact of post-acne scarring.
Jazz Pharmaceutical
Extended-release fluvoxamine and improvements in quality of life in patients with obsessive-compulsive disorder.
Alexza Pharmaceuticals
The pharmacokinetics and bioavailability of prochlorperazine delivered as a thermally generated aerosol in a single breath to volunteers.
BioMarin Pharmaceutical – Lambert-Eaton Myasthenic Syndrome
Genetic variation in aryl N-acetyltransferase results in significant differences in the pharmacokinetic and safety profiles of amifampridine (3,4-diaminopyridine) phosphate.
Erchonia Corporation
A retrospective study of non-thermal laser therapy for the treatment of toenail onychomycosis.
Anacor Pharmaceuticals, Inc.
Tavaborole for the treatment of onychomycosis.
ViraCor-IBT
Cytomegalovirus antiviral resistance: characterization of results from clinical specimens.
ViraCor-IBT
Immunosuppression modifications based on an immune response assay: results of a randomized, controlled trial.
SARCode
The pharmacologic assessment of a novel lymphocyte function-associated antigen-1 antagonist (SAR 1118) for the treatment of keratoconjunctivitis sicca in dogs.
University of California, Davis
Evaluation of the radiographic infrapatellar fat pad sign of the contralateral stifle joint as a risk factor for subsequent contralateral cranial cruciate ligament rupture in dogs with unilateral rupture: 96 cases (2006-2007).
Comparison of the tibial mechanical joint orientation angles in dogs with cranial cruciate ligament rupture.
Carl S. Hörnfeldt, PhD, RPh
Carl is the president of of Apothekon, Inc. He provides medical information and medical writing expertise with an emphasis on specialty diseases to numerous pharmaceutical, biotechnology and medical device companies. He has written or assisted with the publication of over 100 peer-reviewed manuscripts and hundreds of abstracts, standard response letters and other medical information communications for clients in the fields of oncology, dermatology, neurology, ophthalmology and numerous rare diseases such as narcolepsy and liposomal storage disorders. Carl is a graduate of the University of Minnesota College of Pharmacy and College of Veterinary Medicine and the former Director of Medical Information and Drug Safety at Orphan Medical, Inc.
Professional Experience
Orphan Medical, Inc., Minnetonka, MN, 2000-2005
- Director, Medical Information and Drug Safety
Hennepin Regional Poison Center, Minneapolis, MN
- Clinical Coordinator, 1980-2000
Education
University of Minnesota, College of Veterinary Medicine
- Doctor of Philosophy, Pharmacology, 1998
University of Minnesota, College of Pharmacy
- Bachelor of Science, Pharmacy, 1979
University of Minnesota, Duluth
- Bachelor of Science, Biology, 1976
